Finally, after a long (and at times contentious) set of turns around the dance floor, Sanofi and Genzyme have agreed to merge. The big winner? Henri Termeer, who presided over the decline and now …
Impactiviti Daily 061810 Top Pharma News
***** TODAY’S NEWS: Prostate cancer drug treatment (Sanofi) approved on the fast track. But - a warning flag for S-A about possible Lantus/cancer link. Bayer and OncoMed to co-develop oncology …
Continue Reading about Impactiviti Daily 061810 Top Pharma News →
Impactiviti Daily 051210 Top Pharma News
***** TODAY’S NEWS Sanofi taking a heavy dice-roll on Multaq: 11,000-patient trial on expanded use. A glimpse into Merck's late-stage pipeline. Very diverse group of molecules and conditions. …
Continue Reading about Impactiviti Daily 051210 Top Pharma News →
Impactiviti Daily 032910
***** TODAY’S NEWS Antisoma/Novartis experimental drug hits the proverbial wall on Phase III lung cancer trial. Study halted. New test may predict which MS patients will most benefit from beta …
Pharma News 6_6
Fresh news from the ADA (American Diabetes Association): Takeda's alogliptin shows impressive results - Takeda Pharmaceutical Co Ltd's experimental diabetes drug alogliptin significantly lowers …
Pharma Web Branding, Part 6 – Sanofi-Aventis
This is the sixth in an occasionaly series on home page design for pharma companies. Today, we take a look at Sanofi-Aventis. On my marketing blog, I have previously remarked on S-A's logo/tagline …
Continue Reading about Pharma Web Branding, Part 6 – Sanofi-Aventis →